McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools.
| Revenue (TTM) | $403.43B |
| Gross Profit (TTM) | $14.53B |
| EBITDA | $6.88B |
| Operating Margin | 2.21% |
| Return on Equity | 0.00% |
| Return on Assets | 4.99% |
| Revenue/Share (TTM) | $3264.00 |
| Book Value | $-18.10 |
| Price-to-Book | 5.04 |
| Price-to-Sales (TTM) | 0.23 |
| EV/Revenue | 0.24 |
| EV/EBITDA | 13.48 |
| Quarterly Earnings Growth (YoY) | 37.20% |
| Quarterly Revenue Growth (YoY) | 6.00% |
| Shares Outstanding | $120.20M |
| Float | $120.03M |
| % Insiders | 0.06% |
| % Institutions | 93.53% |
Volatility is currently contracting